<DOC>
	<DOCNO>NCT00477308</DOCNO>
	<brief_summary>In HIV-NAT 013 phase I study , genotyping perform 95 child dual NRTI show almost child resistance NRTi . The HIV-NAT 013 phase II follow study evaluate treatment outcome salvage therapy evolution mutation .</brief_summary>
	<brief_title>Genotyping Directed Salvage Therapy Children Who Have Failed Dual NRTIs</brief_title>
	<detailed_description>The HIV-NAT 013 study ( conducted 2003 ) evaluate prevalence pattern RT mutation 95 child treat dual NRTI . The study show almost child degree NRTI resistance 40 % multi NRTI resistance . The mutation report major mutation . After study , patient manage base physician 's judgment use genotyping result . The 95 patient HIV-NAT 013 categorize 3 group . 1 . No viral resistance 2 . Low grade resistance without clinical/ immunological failure 3 . High grade resistance without clinical/ immunological failure . There limited prospective study evaluate outcome decision regard salvage therapy genotyping result There also new mutation consider major mutation may affect treatment outcome Knowledge learn study benefit Thai child NRTI resistance help pediatrician well choose salvage treatment option</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>All child HIVNAT 013 phase I No inform consent obtain</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>HIV child</keyword>
	<keyword>genotypic resistance</keyword>
	<keyword>dual NRTIs</keyword>
	<keyword>Salvage therapy</keyword>
	<keyword>treatment outcome</keyword>
	<keyword>Salvage therapy base genotyping result</keyword>
	<keyword>Treatment Failure</keyword>
</DOC>